Tissue engineering via local gene delivery

Journal of Molecular Medicine

Volumn 78, Issue 6, 2000, Pages 303-311

  Bonadio, Jeffrey ^a  

^a Selective Genetics Inc   (United States)

Author keywords

Gene activated matrix; Gene transfer; Granulation tissue; Growth factor; Wound healing

Indexed keywords

BIOMATERIAL; COLLAGEN TYPE 1; GROWTH FACTOR; PARATHYROID HORMONE[1-34]; PLASMID DNA;

BIOENGINEERING; DOSE RESPONSE; DRUG INTERMITTENT THERAPY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GRANULATION TISSUE; HEALTH CARE COST; HIP FRACTURE; HUMAN; LYOPHILISATE; NONHUMAN; OSTEOPOROSIS; REVIEW; SPONGE; TISSUE REGENERATION; WOUND HEALING;

EID: 0033856380     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090000118     Document Type: Review

References (55)

1. New tissues from old
2. Growing new organs
3. Tissue engineering
4. Wound therapy: Growth factors as agents to promote healing
5. Pathology of recombinant human transforming growth factor-β1 in rats and rabbits
6. Drug delivery and targeting
7. Protein stability in controlled-release systems
8. Sustained delivery of proteins for novel therapeutic products
9. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase
10. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide)
11. Local gene delivery for tissue regeneration. E-biomed
12. Cancer gene therapy using plasmid DNA: Pharmacokinetic study of DNA following injection in mice
13. Issues of large-scale plasmid DNA manufacturing
14. Wound healing- Aiming for perfect skin
15. Localized, direct plasmid-gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration
16. Periodontal tissue engineering by growth factors
17. Stimulation of new bone formation by direct transfer of osteoinductive plasmid genes
18. Controllable DNA delivery from three-dimensional polymer matrices
19. Direct gene transfer into regenerating Achilles' tendon
20. A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle
21. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: The minipellet
22. Gene therapy enters adolescence
23. Principles for human gene therapy studies
24. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: Report from the National Osteoporosis Foundation
25. The direct medical costs of osteoporosis for American women aged 45 and older, 1986
26. Prevalence of low femoral bone density in older US adults from NAHANES III
27. Hip fractures in the elderly: A world-wide projection
28. The worldwide problem of osteoporosis: Insights afforded by epidemiology
29. How many women have osteoporosis now?
30. Consensus summary on the diagnosis and treatment of osteoporosis
31. Fractured neck of the femur: Prevention and management. Summary and recommendation of a report of the Royal College of Physicians
32. Cost analysis of osteoporosis related to untreated menopause
33. Femoral neck fractures: Admissions, bed use, outcome and projections
34. The future of hip fractures in the United States. Numbers, costs and potential effects of postmenopausal estrogen
35. The aging of America: Impact on health care costs
36. Hip fracture prevention: A review
37. Predictors of functional recovery after hip fracture in the elderly
38. Hip fractures are an increasingly important public health problem
39. Eight-year outcome associated with clinical options in the management of femoral neck fractures
40. Outcome after hemiarthroplasty for femoral neck fractures in the elderly
41. Mobility after hip fracture predicts health outcomes
42. Stemming bone loss by suppressing apoptosis
43. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol
44. Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia
45. Daily treatment with human recombinant parathyroid hormone-(1-34), LY33334, for 1 year increases bone mass in ovariectomized monkeys
46. Parathyroid hormone: The clinical experience
47. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence
48. Parathyroid hormone stimulates bone apposition rate independently of its resorptive action: Differential effects of intermittent and continuous administration
49. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response to bone to parathyroid hormone
50. Orthopaedics in the new millennium